Synthesis and Pharmacological Applications of 3-Hydroxy-2-methylpyridine

3-Hydroxy-2-methylpyridine is an important nitrogen-containing heterocyclic organic compound. From a molecular structural perspective, it comprises a pyridine ring core where the 2-position is substituted by a methyl group and the 3-position by a hydroxyl group. This distinctive structure renders it a significant metabolite and structural analogue within the vitamin B₆ (pyridoxine) family. Possessing both basic pyridine nitrogen and acidic phenolic hydroxyl groups, it exhibits typical amphoteric properties, dissolving in both strong acids and strong bases. This characteristic lends it exceptional flexibility in organic synthesis reactions. Within industrial and pharmaceutical applications, 3-hydroxy-2-methylpyridine primarily serves as a fine chemical intermediate. It functions as a key precursor in synthesising numerous pharmaceuticals, holding particular significance in the development of neuropharmaceuticals. Additionally, researchers leverage its structural properties to synthesise antioxidants, enzyme inhibitors, and specific pesticide derivatives. As a pivotal component in the vitamin B6 metabolic pathway, it is frequently employed in biochemical research to investigate coenzyme degradation mechanisms. In summary, owing to its unique chemical reactivity and biological relevance, 3-hydroxy-2-methylpyridine fulfils an irreplaceable foundational role in contemporary medicinal chemistry and the organic synthesis industry.

Novel and selective 5-HT2C receptor inverse agonists

The 5-HT2 receptor family consists of 5-HT2A, 5-HT2B and 5-HT2C subtypes which were grouped together on the basis of their primary structure, secondary messenger system and pharmacological profile. The last few years have seen extensive interest in the development of selective 5-HT2C ligands as potential treatments for a range of CNS disorders, in particular anxiety and depression. We have recently disclosed a number of bispyridyl ethers, such as SB-242084 and SB-243213 which are potent 5-HT2C receptor inverse agonists with selectivity over both the 5-HT2A and 5-HT2B receptors and potent in vivo activity in a number of animal models of anxiety. The 3-hydroxypyridines and 2-chloro-5-nitropyridines were all commercially available or known in the literature. The pyrimidine was similarly prepared starting from 2-chloro-5-nitropyrimidine and 3-hydroxy-2-methylpyridine. The pyridazines were prepared by an analogous route by treating 3-amino-6-chloropyridazine with 3-hydroxy-2-methylpyridine and aqueous sodium hydroxide at high temperature to afford the amino bisarylether which was then coupled with the appropriate indoline as above.[1]

The pyrazine was prepared by reacting 5-chloropyrazinecarboxylic acid methyl ester with 3-hydroxy-2-methylpyridine under basic conditions to give the bisaryl ether. The ester was then converted to the azide which was heated to generate the isocyanate and reacted in situ with 5-methyl-6-trifluoromethylindoline to afford. A number of bisaryl ethers have been identified with excellent 5-HT2C affinity and selectivity over both the 5-HT2A and 5-HT2B receptors in addition to a range of other monoamine receptors, including serotinergic and dopaminergic subtypes. In a human 5-HT2C receptor functional assay they were found to be inverse agonists completely abolishing basal activity.

3-Hydroxypyridine and 3-(Hydroxymethyl)pyridine in Aryldithiophosphonic Acids

Among the pharmacophoric pyridine derivatives, 3-hydroxypyridine was found as a natural product in Paeonia lactiflora and Salvia divinorum. 3-Hydroxypyridine and its derivatives possess therapeutic properties. The antithyphoxic effect of 3-hydroxypyridine and succinic acid derivatives was established. 2-Ethyl-6-methyl-3-hydroxypyridinium N-acetyl-L-glutamate has acute hypoxia and a neuroprotective effect on rats. The decreasing of the anxiolytic effect of mexidol as a mixture of 3-hydroxypyridine cation and succinate anion was detected. Mexidol (2-ethyl-6-methyl-3-hydroxypyridinium succinate) was used for the solubilization of magnetite nanoparticles in hydrophilic medium. 3-Hydroxy-2-methylpyridine, a member of the 3-hydroxypyridine derivative family, has been shown to abolish lysozyme fibril formation associated with protein-misfolding disorders, including prevalent neurodegenerative diseases. Unlike 3-Hydroxy-2-methylpyridine, which lacks antimicrobial activity, the newly synthesized 3-hydroxypyridinium and 3-(hydroxymethyl)pyridinium O-terpenyl aryldithiophosphonates exhibit potent antimicrobial effects against Bacillus cereus and Candida albicans, highlighting the distinct pharmacological profiles of different 3-hydroxypyridine-based compounds. The synthesis of 3-hydroxypyridinium and 3-(hydroxymethyl)pyridinium O-terpenyl aryldithiophosphonates has been successfully carried out. These salts were obtained by reacting O-terpenyl aryldithiophosphonic acids with 3-hydroxypyridine and 3-(hydroxymethyl)pyridine under mild conditions. Ethanol is the best organic solvent for these reactions and promotes the formation of ionic products. 3-(Hydroxymethyl)pyridinium aryldithiophosphonate bearing a O-carvacrol substituent exhibits remarkable antifungal activity toward Candida albicans. The obtained results seem promising for carrying out the next steps in the antimicrobial activity study.[2]

References

[1]Bromidge, S M et al. “1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolytic agents.” Bioorganic & medicinal chemistry letters vol. 10,16 (2000): 1863-6. doi:10.1016/s0960-894x(00)00364-4

[2]Nizamov, I., Yakovlev, A., Nizamov, I., & Shulaeva, M. (2023). 3-Hydroxypyridine and 3-(Hydroxymethyl)pyridine in the Synthesis of Salts of Aryldithiophosphonic Acids on the Basis of Monoterpenyl Alcohols. Journal of the Turkish Chemical Society Section A: Chemistry, 10(4), 953–960.

You may like